Find Federal Grants

Showing 3981–4000 of 11,651 grants
Power tools: Sign in to save searches, get reminders, export CSV, and use advanced filters. Sign in

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · PAR-19-150

Closes: Jan 7, 2022 Up to: $200,000

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

★ Save Archived

National Institutes of Health · PAR-19-159

Closes: May 7, 2022

Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-146

Closes: Jan 7, 2022 Up to: $200,000

Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-147

Closes: Jan 7, 2022

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-19-158

Closes: May 7, 2022

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-026

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-025

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-024

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-023

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-027

Closes: Sep 27, 2019 Up to: $150,000 Program funding: $600,000

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-028

Closes: Sep 27, 2019 Up to: $150,000

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-019

Closes: Sep 27, 2019 Up to: $200,000 Program funding: $4,200,000

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-020

Closes: Sep 27, 2019 Up to: $300,000 Program funding: $4,300,000

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-021

Closes: Sep 27, 2019 Up to: $200,000 Program funding: $1,000,000

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

★ Save Archived

National Institutes of Health · RFA-CA-19-022

Closes: Sep 27, 2019 Up to: $300,000 Program funding: $900,000

U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-CA-19-009

Closes: Feb 21, 2019 Up to: $150,000 Program funding: $4,600,000

Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · RFA-DA-19-031

Closes: Mar 4, 2019 Program funding: $2,000,000

Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · RFA-DA-19-030

Closes: Mar 4, 2019 Program funding: $1,150,000

Office of Innovation and Improvement (OII): Charter Schools Program (CSP): Grants to State Entities CFDA Number 84.282A

★ Save Archived

Department of Education · ED-GRANTS-122818-001

Closes: Feb 12, 2019 Program funding: $108,000,000

NAGPRA Repatriation Grants FY2019

★ Save Archived

National Park Service · P19AS00009

Closes: May 17, 2019 Up to: $15,000 Program funding: $1,654,000